Among the Zacks Rank #1 (Strong Buy) list, electronics manufacturer Celestica (CLS)  and oncology-focused biotech firm Exelixis (EXEL)  are two highly ranked stocks that are worthy of consideration after exceeding their Q2 earnings expectations on Monday evening.Although Celestica and Exelixis stock moved in different directions in Tuesday's trading session, both have set up intriguing buying opportunities following their Q2 reports. Celestica Stock Hits an All-Time HighExceeding Q2 top and bottom line expe ...